(Q43048164)

English

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

scientific article published in June 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study (English)
Pierre Wijermans
Martijn Schaafsma
Fabian Termorshuizen
Rianne Ammerlaan
Shulamiet Wittebol
Marinus van Marwijk Kooy
René van der Griend
Dutch-Belgium Cooperative Group HOVON

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit